4//SEC Filing
GELBMAN RONALD G 4
Accession 0001127602-19-032642
CIK 0000313143other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 5:21 PM ET
Size
12.2 KB
Accession
0001127602-19-032642
Insider Transaction Report
Form 4
GELBMAN RONALD G
Director
Transactions
- Exercise/Conversion
Common Stock
2019-11-11$45.45/sh+6,573$298,743→ 54,957 total - Exercise/Conversion
Common Stock
2019-11-11$35.50/sh+10,353$367,552→ 65,310 total - Sale
Common Stock
2019-11-11$118.26/sh−16,926$2,001,669→ 48,384 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2019-11-11−10,353→ 0 totalExercise: $35.50From: 2015-07-23Exp: 2021-07-23→ Common Stock (10,353 underlying) - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2019-11-11−6,573→ 0 totalExercise: $45.45From: 2014-07-24Exp: 2020-07-24→ Common Stock (6,573 underlying)
Footnotes (3)
- [F1]This number includes unvested restricted stock units previously reported.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.97 to $118.83, inclusive. the reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
- [F3]Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001210616
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 5:21 PM ET
- Size
- 12.2 KB